Annual ROE
3.52%
+26.53%+115.30%
December 1, 2023
Summary
- As of March 10, 2025, ORMP annual return on equity is 3.52%, with the most recent change of +26.53% (+115.30%) on December 1, 2023.
- ORMP annual ROE is now -96.56% below its all-time high of 102.23%, reached on August 31, 2005.
Performance
ORMP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
2.69%
-10.02%-78.84%
September 1, 2024
Summary
- As of March 10, 2025, ORMP quarterly return on equity is 2.69%, with the most recent change of -10.02% (-78.84%) on September 1, 2024.
- Over the past year, ORMP quarterly ROE has dropped by -0.90% (-25.07%).
- ORMP quarterly ROE is now -99.97% below its all-time high of 8057.41%, reached on November 30, 2007.
Performance
ORMP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ORMP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +115.3% | -25.1% |
| 3 y3 years | - | +110.1% |
| 5 y5 years | +106.2% | +104.7% |
ORMP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +115.3% | -78.8% | +109.5% |
| 5 y | 5-year | at high | +106.2% | -78.8% | +104.3% |
| alltime | all time | -96.6% | +100.6% | -100.0% | +100.2% |
Oramed Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 2.69%(-78.8%) |
| Jun 2024 | - | 12.71%(+91.7%) |
| Mar 2024 | - | 6.63%(+84.7%) |
| Dec 2023 | 3.52%(-115.3%) | 3.59%(-133.1%) |
| Sep 2023 | - | -10.84%(-18.6%) |
| Jun 2023 | - | -13.32%(-30.6%) |
| Mar 2023 | - | -19.18%(-17.1%) |
| Dec 2022 | -23.01%(+179.2%) | -23.13%(-2.7%) |
| Sep 2022 | - | -23.76%(-10.6%) |
| Jun 2022 | - | -26.58%(-0.6%) |
| Mar 2022 | - | -26.74%(-5.5%) |
| Dec 2021 | -8.24%(-72.3%) | - |
| Nov 2021 | - | -28.29%(-24.6%) |
| Aug 2021 | -29.77%(-32.4%) | -37.53%(-12.7%) |
| May 2021 | - | -42.98%(-10.6%) |
| Feb 2021 | - | -48.09%(-15.0%) |
| Nov 2020 | - | -56.59%(+17.6%) |
| Aug 2020 | -44.04%(-22.5%) | -48.11%(-3.5%) |
| May 2020 | - | -49.83%(-21.2%) |
| Feb 2020 | - | -63.20%(+12.7%) |
| Nov 2019 | - | -56.07%(-1.4%) |
| Aug 2019 | -56.85%(+12.5%) | -56.84%(-6.4%) |
| May 2019 | - | -60.72%(-2.7%) |
| Feb 2019 | - | -62.40%(+3.2%) |
| Nov 2018 | - | -60.48%(+4.8%) |
| Aug 2018 | -50.55%(+9.6%) | -57.73%(-8.6%) |
| May 2018 | - | -63.16%(+29.5%) |
| Feb 2018 | - | -48.79%(+0.7%) |
| Nov 2017 | - | -48.44%(+2.2%) |
| Aug 2017 | -46.14%(+7.4%) | -47.40%(-7.6%) |
| May 2017 | - | -51.29%(+10.3%) |
| Feb 2017 | - | -46.51%(+13.2%) |
| Nov 2016 | - | -41.09%(+5.3%) |
| Aug 2016 | -42.98%(+47.5%) | -39.01%(+30.2%) |
| May 2016 | - | -29.97%(-3.9%) |
| Feb 2016 | - | -31.19%(-8.1%) |
| Nov 2015 | - | -33.95%(+8.2%) |
| Aug 2015 | -29.13% | -31.38%(+2.5%) |
| May 2015 | - | -30.60%(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | -31.49%(+9.3%) |
| Nov 2014 | - | -28.81%(-7.2%) |
| Aug 2014 | -27.39%(-47.4%) | -31.04%(-3.0%) |
| May 2014 | - | -31.99%(-19.9%) |
| Feb 2014 | - | -39.94%(-43.6%) |
| Nov 2013 | - | -70.80%(-0.5%) |
| Aug 2013 | -52.05%(-41.2%) | -71.16%(-27.5%) |
| May 2013 | - | -98.19%(+4.2%) |
| Feb 2013 | - | -94.27%(-11.3%) |
| Nov 2012 | - | -106.25%(-8.9%) |
| Aug 2012 | -88.51%(+111.1%) | -116.66%(+19.4%) |
| May 2012 | - | -97.70%(+90.5%) |
| Feb 2012 | - | -51.28%(+30.7%) |
| Nov 2011 | - | -39.24%(-23.7%) |
| Aug 2011 | -41.92%(-88.3%) | -51.42%(-39.2%) |
| May 2011 | - | -84.51%(-57.4%) |
| Feb 2011 | - | -198.30%(-9.4%) |
| Nov 2010 | - | -218.80%(+28.8%) |
| Aug 2010 | -358.59%(+256.7%) | -169.83%(+71.4%) |
| May 2010 | - | -99.10%(+30.6%) |
| Feb 2010 | - | -75.87%(-2.9%) |
| Nov 2009 | - | -78.12%(-11.9%) |
| Aug 2009 | -100.52%(+66.7%) | -88.70%(-12.4%) |
| May 2009 | - | -101.26%(-23.4%) |
| Feb 2009 | - | -132.15%(-16.6%) |
| Nov 2008 | - | -158.50%(-12.5%) |
| Aug 2008 | -60.29%(-90.4%) | -181.21%(-77.3%) |
| May 2008 | - | -797.45%(-55.3%) |
| Feb 2008 | - | -1782.87%(-122.1%) |
| Nov 2007 | - | 8057.41%(+734.5%) |
| Aug 2007 | -630.80%(-758.3%) | 965.54%(+460.7%) |
| May 2007 | - | 172.19%(-10.9%) |
| Feb 2007 | - | 193.17%(+15.1%) |
| Nov 2006 | - | 167.87%(-27.9%) |
| Aug 2006 | 95.82%(-6.3%) | 232.86%(+61.7%) |
| May 2006 | - | 144.04%(+898.2%) |
| Feb 2006 | - | 14.43%(+26.0%) |
| Nov 2005 | - | 11.45% |
| Aug 2005 | 102.23% | - |
FAQ
- What is Oramed Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual ROE year-on-year change?
- What is Oramed Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly ROE year-on-year change?
What is Oramed Pharmaceuticals annual return on equity?
The current annual ROE of ORMP is 3.52%
What is the all time high annual ROE for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual return on equity is 102.23%
What is Oramed Pharmaceuticals annual ROE year-on-year change?
Over the past year, ORMP annual return on equity has changed by +26.53% (+115.30%)
What is Oramed Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ORMP is 2.69%
What is the all time high quarterly ROE for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly return on equity is 8057.41%
What is Oramed Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ORMP quarterly return on equity has changed by -0.90% (-25.07%)